Zichao Luo

3.1k citations
51 papers · 2.5k indexed · 1 hit paper · h-index 29

Zichao Luo

50 papers receiving 2.4k citations

Hit Papers

Mitochondria-Targeting Type-I Photodrug: Harnessing Caspa...67202420262025204060

Peers

Zichao Luo
Comparison fields: 5 of 123
  • Biomaterials 592
  • Pharmaceutical Science 223
  • Immunology 646
  • Molecular Medicine 127
  • Biomedical Engineering 974
Replace Evan A. Scott with:
Evan A. Scott United States
Eiji Yuba Japan
Lutz Nuhn Germany
Huijuan Song China
Kyuri Lee South Korea
Feihu Wang United States
Todd D. Giorgio United States
Richard Tsai United States
Anthony J. Convertine United States
Yuhua Weng China
Zichao Luo relative to Evan A. Scott United States Evan A. Scott's profile →
Citations per field
00.5×1.5×2.3×
Evan A. Scott · 1×
Citations per year

Countries citing papers authored by Zichao Luo

Since Specialization
Citations

This map shows the geographic impact of Zichao Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zichao Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zichao Luo more than expected).

Fields of papers citing papers by Zichao Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zichao Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zichao Luo. The network helps show where Zichao Luo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zichao Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zichao Luo Line = papers co-authored together Zichao Luo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20243
3 202434
4
Mitochondria-Targeting Type-I Photodrug: Harnessing Caspase-3 Activity for Pyroptotic Oncotherapybreakdown →
202467
5 202417
6 20236
7 202339
8 202357
9 202159
10 2020130
11 20156
12 201518
13 201594
14 201430
15 201419
16 201341
17 201373
18 201212
19 201263
20 201010

About Zichao Luo

Zichao Luo is a scholar working on Immunology, Pharmaceutical Science and Biomaterials, having authored 51 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (18 papers), Immunotherapy and Immune Responses (17 papers), RNA Interference and Gene Delivery (13 papers), Nanoparticle-Based Drug Delivery (6 papers), Ocular Surface and Contact Lens (5 papers), Advanced Nanomaterials in Catalysis (4 papers), Advanced Drug Delivery Systems (4 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Biomaterials (592 citations), Pharmaceutical Science (223 citations) and Immunology (646 citations). Zichao Luo has collaborated with scholars based in China, Singapore and United Kingdom. Frequent co-authors include Xiaogang Liu, Zhigao Yi, Xingyi Li, Changyang Gong, Hao Chen, Yifan Ma, Hong Pan, Lanlan Liu, Tao He and Shuai Shi. Their work appears in journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026